| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 144, 767-775, Copyright © 1994 by American Society for Investigative Pathology
REGULAR ARTICLES |
P Chaubert, J Benhattar, E Saraga and J Costa
Institut Universitaire de Pathologie, Lausanne, Switzerland.
We have analyzed K-ras mutations and p53 alterations in 39 tumor and nontumor samples taken from nine patients with longstanding ulcerative colitis and colorectal carcinoma. Two of nine invasive carcinomas contained a K-ras mutation. By a combination of immunohistochemistry and single-strand conformation polymorphism analysis, p53 alterations were found in three of nine carcinomas. Five of 13 dysplastic lesions harbored a mutated K-ras gene, even in the absence of detectable changes in associated invasive tumors. One single focus of dysplastic mucosa harbored concomitant K-ras and p53 gene alterations. In two patients, a K-ras mutation was detected in epithelial lesions considered to be devoid of malignant potential (villous regeneration, active colitis). Our results indicate that: 1) the prevalence of K-ras and p53 genetic alterations found in ulcerative colitis-associated colonic carcinomas appears to be lower than in sporadic carcinomas; 2) K-ras mutations can be detected in dysplasia, villous regeneration, and active colitis and affect a subpopulation of the cells composing the lesions; 3) diverse genetic alterations can be detected in the same patient and the dysplastic lesions can exhibit a different genotype than the carcinomas; and 4) at least part of active colitis and villous regeneration lesions should be considered as preneoplastic in ulcerative colitis.
This article has been cited by other articles:
![]() |
C. Santiago, B. Pagan, A. A. Isidro, and C. B. Appleyard Prolonged Chronic Inflammation Progresses to Dysplasia in a Novel Rat Model of Colitis-Associated Colon Cancer Cancer Res., November 15, 2007; 67(22): 10766 - 10773. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Watari, A Tanaka, H Tanabe, R Sato, K Moriichi, A Zaky, K Okamoto, A Maemoto, M Fujiya, T Ashida, et al. K-ras mutations and cell kinetics in Helicobacter pylori associated gastric intestinal metaplasia: a comparison before and after eradication in patients with chronic gastritis and gastric cancer J. Clin. Pathol., August 1, 2007; 60(8): 921 - 926. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Fujii, T Fujimori, H Kawamata, J Takeda, K Kitajima, F Omotehara, T Kaihara, T Kusaka, K Ichikawa, Y Ohkura, et al. Development of colonic neoplasia in p53 deficient mice with experimental colitis induced by dextran sulphate sodium Gut, May 1, 2004; 53(5): 710 - 716. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. Seril, J. Liao, G.-Y. Yang, and C. S. Yang Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models Carcinogenesis, March 1, 2003; 24(3): 353 - 362. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Sato, N. Harpaz, D. Shibata, Y. Xu, J. Yin, Y. Mori, T.-T. Zou, S. Wang, K. Desai, A. Leytin, et al. Hypermethylation of the p14ARF Gene in Ulcerative Colitis-associated Colorectal Carcinogenesis Cancer Res., February 1, 2002; 62(4): 1148 - 1151. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-J. Sohn, S. A. Shah, S. Reid, M. Choi, J. Carrier, M. Comiskey, C. Terhorst, and Y.-I. Kim Molecular Genetics of Ulcerative Colitis-associated Colon Cancer in the Interleukin 2- and {beta}2-Microglobulin-deficient Mouse Cancer Res., September 1, 2001; 61(18): 6912 - 6917. [Abstract] [Full Text] [PDF] |
||||
![]() |
J M D Wheeler, H C Kim, J A Efstathiou, M Ilyas, N J M. Mortensen, and W F Bodmer Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer Gut, March 1, 2001; 48(3): 367 - 371. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kado, K. Uchida, H. Funabashi, S. Iwata, Y. Nagata, M. Ando, M. Onoue, Y. Matsuoka, M. Ohwaki, and M. Morotomi Intestinal Microflora Are Necessary for Development of Spontaneous Adenocarcinoma of the Large Intestine in T-Cell Receptor {beta} Chain and p53 Double-Knockout Mice Cancer Res., March 1, 2001; 61(6): 2395 - 2398. [Abstract] [Full Text] |
||||
![]() |
H. S. Cooper, S. Murthy, K. Kido, H. Yoshitake, and A. Flanigan Dysplasia and cancer in the dextran sulfate sodium mouse colitis model. Relevance to colitis-associated neoplasia in the human: a study of histopathology, B-catenin and p53 expression and the role of inflammation Carcinogenesis, April 1, 2000; 21(4): 757 - 768. [Abstract] [Full Text] [PDF] |
||||
![]() |
S N Andersen, T Lovig, O P F Clausen, A Bakka, O Fausa, and T O Rognum Villous, hypermucinous mucosa in long standing ulcerative colitis shows high frequency of K-ras mutations Gut, November 1, 1999; 45(5): 686 - 692. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. Willenbucher, D. E. Aust, C. G. Chang, S. J. Zelman, L. D. Ferrell, D. H. Moore II, and F. M. Waldman Genomic Instability Is an Early Event during the Progression Pathway of Ulcerative-Colitis-Related Neoplasia Am. J. Pathol., June 1, 1999; 154(6): 1825 - 1830. [Abstract] [Full Text] [PDF] |
||||
![]() |
M M Entius, A M Westerman, F M Giardiello, M-L F van Velthuysen, M M Polak, R J C Slebos, J H P Wilson, S R Hamilton, and G J A Offerhaus Peutz-Jeghers polyps, dysplasia, and K-ras codon 12 mutations Gut, September 1, 1997; 41(3): 320 - 322. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |